KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Amneal Pharmaceuticals (AMRX) Inventory Average (2018 - 2025)

Historic Inventory Average for Amneal Pharmaceuticals (AMRX) over the last 8 years, with Q3 2025 value amounting to $611.7 million.

  • Amneal Pharmaceuticals' Inventory Average rose 439.34% to $611.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $611.7 million, marking a year-over-year increase of 439.34%. This contributed to the annual value of $596.9 million for FY2024, which is 734.8% up from last year.
  • Amneal Pharmaceuticals' Inventory Average amounted to $611.7 million in Q3 2025, which was up 439.34% from $605.2 million recorded in Q2 2025.
  • Amneal Pharmaceuticals' 5-year Inventory Average high stood at $611.7 million for Q3 2025, and its period low was $493.8 million during Q1 2021.
  • Moreover, its 5-year median value for Inventory Average was $539.8 million (2023), whereas its average is $552.9 million.
  • Its Inventory Average has fluctuated over the past 5 years, first skyrocketed by 2058.92% in 2021, then surged by 141.48% in 2022.
  • Amneal Pharmaceuticals' Inventory Average (Quarter) stood at $504.8 million in 2021, then rose by 6.43% to $537.3 million in 2022, then increased by 7.75% to $578.9 million in 2023, then increased by 4.4% to $604.4 million in 2024, then grew by 1.21% to $611.7 million in 2025.
  • Its Inventory Average stands at $611.7 million for Q3 2025, versus $605.2 million for Q2 2025 and $606.9 million for Q1 2025.